 |
Quick Links |
| Information by Disease |
|
|
 |
| Cancer News |
|
|
 |
| Conference Coverage |
|
|
 |
| AZN | $44.82 | -0.37 (-0.82%)
| | NVS | $53.13 | -0.16 (-0.3%)
| | SNY | $37.67 | -0.01 (-0.03%)
| | GSK | $41.53 | 0.06 (0.14%)
|
|
 |
Supportive Care – Stem Cell Stimulator
| AMD 3100 |
CXCR-4 chemokine receptor antagonist |
Anormed Inc. |
II |
| HYC 750 |
Stem cell mobilizer |
BioMs |
I |
| MARStem |
Multiple blood cell stimulator |
Transkaryotic Therapeutics |
I |
|
For more information contact us at clinicaltrials@cancerconsultants.com
 |
View Drugs in Pipeline By Disease |
 |
|
|
|
 |
|
 |
|
|